On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India